Efficacy and Safety of Repaglinide Combined With Insulin NPH in Subjects With Type 2 Diabetes
Clinical trial NCT01562561 · COMPLETED
Trial details
- NCT number
- NCT01562561
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2001-06-01
- Primary completion
- 2002-12-20
- Enrollment
- 213
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.